BEWARE OF FRAUDULENT SCHEMES CLAIMING TO REPRESENT PT VERDHANA SEKURITAS INDONESIA

• Please be cautious of any fraudulent schemes conducted by parties claiming to represent PT Verdhana Sekuritas Indonesia. These scams often use the name, logo, and identity of PT Verdhana Sekuritas Indonesia to pose as official company representatives.
  
• Identified scam methods include investment fraud, job offers, task assignments, or other programs that appear to offer monetary rewards or commissions. Please remain vigilant against other forms of fraud as well.
  
• These scams may be carried out through various media channels, including:
  1. Fake websites;
  2. Messaging apps such as WhatsApp, Telegram, SMS, etc.;
  3. Fake emails and letters;
  4. Fraudulent phone calls. 
• PT Verdhana Sekuritas Indonesia operates solely as a Securities Broker-Dealer and Underwriter. We are not an investment manager or an institution that offers investment programs, job offers, commission-based tasks, or other financial schemes directly to the public via social media, private messages, phone calls, or unofficial individual agents. We do not appoint any individual or third party to collect funds from the public. 
• We never request the public, prospective clients, or our clients to (1) conduct cash transactions or (2) transfer funds to any personal account of individuals claiming to be employees or representatives of PT Verdhana Sekuritas Indonesia.
  
• Official information from PT Verdhana Sekuritas Indonesia is communicated only through our official channels:
  Website: www.verdhana.id and www.verdhanaresearch.com 
  Email: info@verdhana.id
  Phone: (021) 5098 5799
  Address: Deutsche Bank Building, 18th Floor, Jl. Imam Bonjol No. 80, Jakarta 10310 
• If you receive any suspicious messages, offers, or solicitations conducted by parties claiming to represent PT Verdhana Sekuritas Indonesia, please do not respond and report them immediately to us via email at info@verdhana.id.

This announcement is hereby conveyed. Thank you for your attention and for placing your trust in PT Verdhana Sekuritas Indonesia.
Sincerely,

PT Verdhana Sekuritas Indonesia

 CLOSE 

Home   /   Latest Research

Default sorting Sort by Popularity Sort by Average rating Sort by Featured

• Indonesia Retailers - When growth starts paying back

  JW SH NY SC

  Indonesia's listed retailers are arguably in their healthiest...

  RETAIL Indonesia Retailers Jody Wijaya Sandy Ham Nayla Yasmin Samuel Christian

  2 weeks ago

• Siloam International Hospitals (SILO IJ) (Buy) - Stronger governance boosts long-term value

  JW SH NY SC

  Siloam International Hospitals’ 1Q26 revenue...

  HEALTH CARE AND PHARMACEUTICALS Siloam International Hospitals SILO SILO JK SILO IJ Jody Wijaya Sandy Ham Nayla Yasmin Samuel Christian

  3 months ago

• Medikaloka Hermina (HEAL IJ) (Buy) - Short-term volume pressure still lingering

  JW SH NY SC

  Earlier festive timing and tighter BPJS....

  HEALTH CARE AND PHARMACEUTICALS Medikaloka Hermina HEAL HEAL JK HEAL IJ Jody Wijaya Sandy Ham Nayla Yasmin Samuel Christian

  3 months ago

• Mitra Keluarga Karyasehat (MIKA IJ) (Buy) - Better mix and better margins ahead

  JW SH NY SC

  Mitra’s 1Q26 revenue came in softer than...

  HEALTH CARE AND PHARMACEUTICALS Mitra Keluarga Karyasehat MIKA MIKA JK MIKA IJ Jody Wijaya Sandy Ham Nayla Yasmin Samuel Christian

  3 months ago

• Indonesia equity strategy - Corporate health check: Slowest growth of wallet size in a decade

  JT GH FJ

  We have compiled the 1Q26 results across 250...

  EQUITY STRATEGY Indonesia equity strategy Jupriadi Tan Gerald Hugo Felix Justin

  3 months ago

• Medela Potentia (MDLA IJ) (Buy) - Compounder in healthcare & logistics segments

  JT DT

  We initiate coverage of MDLA with a Buy...

  HEALTH CARE AND PHARMACEUTICALS Medela Potentia MDLA MDLA JK MDLA IJ Jupriadi Tan David Tjahjadi

  6 months ago

• Kalbe Farma (KLBF IJ) (Buy) - The new era of consumer health

  SH SC JW

  We have tracked the progress of KLBF consumer health’s brand...

  GENERAL CONSUMER Kalbe Farma KLBF KLBF JK KLBF IJ Sandy Ham Samuel Christian Jody Wijaya

  9 months ago

• Indonesia Equity Strategy - 2Q25 corporate health check

  JT GH DT FJ

  We have compiled data from 260 companies in the JCI...

  EQUITY STRATEGY Indonesia Equity Strategy Jupriadi Tan Gerald Hugo David Tjahjadi Felix Justin

  11 months ago

• Indonesia Telecom - Fragile equilibrium

  EW

  Across major telcos, we anticipate growing efforts to foster a healthier market environment.

  TELECOMS Erwin Wijaya

  1 year ago

• Kalbe Farma (KLBF IJ) (Buy) - Brand transformation in progress

  SH JW SC

  We estimate KLBF booked 7-8% y-y sales growth in 4Q24F, driven by its pharma and consumer health divisions.

  General Consumer KLBF KLBF JK KLBF IJ Sandy Ham Jody Wijaya Samuel Christian

  1 year ago

• Indonesia Healthcare - Opportunities in the medical devices sector

  SH JW SC

  Based on our conversation with industry players and data from Indonesia Association of Medical Devices Manufac

  Health care Pharmaceuticals Sandy Ham Jody Wijaya Samuel Christian

  1 year ago

• Indonesia FMCG - Nutri-Grade labellings impact on consumers

  SH JW SC

  The Minister of Health (MoH) plans to implement the Nutri-Grade labelling system for beverages

  Food and Beverage Sandy Ham Jody Wijaya Samuel Christian

  1 year ago

• Kalbe Farma KLBF IJ -Buy- Transforming the brand

  SH JW SC

  Consumer health is a very crucial division for KLBF, as it possesses the highest margin,

  General Consumer Kalbe KLBF JK KLBF IJ Sandy Ham Jody Wijaya Samuel Christian

  2 years ago

• Indonesia Healthcare - Strong as expected

  JW SH SC EM

  2Q24 review: Healthcare still showed some of the strongest sector growth in JCI Index Overall strong result

  Health Care Pharmaceuticals Jody Wijaya Sandy Ham Samuel Christian Elvira Mulia

  2 years ago